For the past twenty years, Nathalie has worked in the field of vaccine development for both profit and non-profit organizations, last nine years of which were for the European Vaccine Initiative (EVI), two years for the Meningitis Vaccine Project and nine years for GlaxoSmithKline.
Since 1996, she joined SmithKline Beecham France to work on the pediatric combo, pneumococcal vaccine, HSV and Flu prophylactic vaccines. In 2003, she moved as Clinical Operations Manager to the Meningitis Vaccine Project a partnership between PATH and WHO. As part of her duties, she set up a multicultural project team, with remote partners in India, USA, and Europe, which initiated the phase I vaccine trial in India. In 2005, she was called to lead the clinical operations for the development of a pneumococcal vaccine in ID Biomedical, Laval, Canada.
In 2007 she joined the European Vaccine Initiative, (formerly European Malaria Vaccine Initiative) as Clinical Operations Manager in Copenhagen, Denmark, until 2010, when she took the responsibility of the quality assurance and the external relations of the organization. In 2012 she was promoted Quality Assurance, External Relations, and Communication Director, and in 2013 Secretary of the Governance of EVI in Heidelberg, Germany.
She joined the Coalition for Epidemic Preparedness Innovations (CEPI), as Global Development Programme Manager, on 12th March 2018. She is in charge of the management of three projects for Lassa fever, Nipah, and MERS-CoV vaccines candidates.